Bullish momentum on Natco pharmaBullish momentum on Natco pharma
I have clearly mentioned the buying level and targets fir the Natco pharma in this chart
Natco pharma buy @1280 -1300
Target 1400 , 1450 & 1500
NATCOPHARM trade ideas
NATCO PHARMA - On Radar | 7 years ATH BOPrice Analysis & Overview:
1. Double bottom on monthly.
2. Volumes on BO is not really great.
3. If the price sustains at higher levels, I will plan an entry.
4. RRR is favourable. Potenial is huge!
5. Earnings are strong.
Monthly TF view:
- Stay tuned for further insights, updates and trade safely!
- These are my personal views.
- If you liked the analysis, don't forget to leave a comment and boost the post. Happy trading!
Disclaimer: This is NOT a buy/sell recommendation. This post is meant for learning purposes only. Please, do your due diligence before investing.
Thanks & Regards,
Anubrata Ray
Classic head & shoulder now 1473 looks attractive Natco PharmaHi Investor,
Chart looks attractive stock near 52 week's high. Today pharma index supporting advise.
Stop loss and target as mentioned on chart. Correction done in Natco pharma.
Inverted Head & shoulder is formed when recent down trend gets reversal.
In Natco Pharma same condition is forming.
Have Patience to wait in the stock with strict stop loss.
I or you never know future it is just projections of future.
Trade at own risk I am not advisor better Observe stock performance to gain in future and stick to condition of Inverted Head & Shoulder pattern only.
Well wisher Happy Investing
Natco Pharma's underlying stength is apparent I believe this is a good time to take position in Natco
- parallel channel bottom has been made
- fibonacci level bouncing in between 0.618 and 5
- price closing above red cloud as per ichimoku and retraced once.. the green cloud is visible at the end..
the signal seems loud enough to me
Perfect Time for a Long Entry.Natco Pharma has clearly turned it's way now, after a fall of more than 20% from it's ATH, is has shown some good reversal confirmations, first being it has take rejection form Fibonacci 0.5 level as well as From it's Important Support Zone, Second being formation of two Bullish Chart Pattern i.e. Inverted Head & Shoulders and Falling Wedge pattern and it has given breakout of these pattern too. There are higher probabilities of it going towards a New ATH.
simple pattern based tradeAfter correcting a fair bit from its recently made all time highs my favourite pharma stock has been going in a zig zag manner while fundamentally it recently sold certain non core assets for some 150 odd crores... so whats cooking, will it announce the first of its long awaited brownfield acquisitons?
Anyhow, it has formed a symmetrical triangle and the same should cleanly breakout between 10th and 17th dec, both dates included... target is near to its ATH of 1636... Although I may hold upto 17th dec as long as the price remains within the triangle, it is prudent to keep SL of 1400 on daily closing basis...
NATCOPHARMA Ready to BreakOut?NATCOPHARMA has been trading in a ascending triangle pattern. Multiple supports taken on the base line, last daily candle formed green candle on the base and range is very narrow. Likely to breakout sloping TL.
Lower side, Previous swing low can be the SL
Natco Pharma for 45%+ gainsDate: 21 Nov’24
Symbol: NATCOPHARM
Timeframe: Daily
Natco Pharma currently seems to be in Wave IV of 3 which could end around 1240-1220 and Wave V could then head towards 1800-1900 levels (45%+ from where Wave IV would end) as seen in the chart. A more precise target can be pinned once it makes a fresh ATH. Two levels (1770 & 1900) have been marked as possible supply zone.
The company recently posted good Q2 numbers. The stock is currently trading at a PE multiple of 12.6 while the industry average is around 32.
This is not a prediction but a possible wave count. This is also not a recommendation to trade or invest. Please do your own analysis.
HINGLISH VERSION
Natco Pharma vartamaan mein 3 ke Wave IV mein hai, jo 1240-1220 ke aaspaas samaapt ho sakta hai aur Wave V phir 1800-1900 ke star (45%+ jahaan Wave IV samaapt hoga) kee taraf badh sakta hai, jaisa ki chart mein dekh sakte hain. Ek baar naya ATH banaane par adhik sateek target pin kiya ja sakta hai. Do staron (1770 aur 1900) ko sambhaavit supply zone ke roop mein mark kiya gaya hai.
Company ne haal hee mein achhe Q2 ke numbers post kiye hain. Stock vartamaan mein 12.6 ke PE multiple par kaarobaar kar raha hai jabki industry ka average lagbhag 32 hai.
Yah koee bhavishyavaanee nahin balki sambhaavit Wave count hai. Yah trade lene ya invest karne ki bhi salaah nahi hai. Kripya apana vishleshan svayan karen.
NPL--Breakout and retest
--8 years consolidation breakout
Disclaimer:
- The view expressed here is my personal view
- Any decision you take, you need to take responsibility for the same
- It's your hard earned money. Treat it wisely
- Trade / Invest keeping in mind your trading style, goals and objectives, time horizon & risk tolerance
-- Do your own analysis and consult your financial adviser if needed
Day Trade set upI am looking this could give an around 3.8 % Profits in a day or two
One must know the entry is always on Bullish Brake out with pre defined stop
This is an Education content derived by Wave Theory
Thanks
Natco PharmaDate 12.09.2024
Natco Pharma
Timeframe : Weekly
Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Natco Pharma cash from the operating activity was Rs 1,196.40 Cr.
Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Natco Pharma has a Debt to Equity ratio of 0.06 , which is a strong indication for the company.
EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Natco Pharma , the EPS growth was 109.10 % which is good for the company.
Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Natco Pharma has OPM of 45.87 % which is a good sign for profitability.
ROE: Natco Pharma have a healthy ROE of 25.38 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
Regards,
Ankur
Natco - Long term Investing Story Natco at all time high of 1190+
Recently crossed previous lifetime highs of 1150, 1050 and 950.
PEG Ratio < 1
PE is 15.4 , less than Industry PE of 38
Low Debt , D/E is 0.06 , High ICR of 88
ROE, ROCE is 25+
Good sales and profit growth, sales 5 years is 14% and profit growth 5 years is 17%
Promoter holding is rock solid ~49%
FII have upped their stake in last 2 years
Not a recommendation. Not SEBI registered
Natco - Short term DARVAS technical trade Natco - Short term technical trade
Fundamentals
MCAP- 28000 Cr
PE - 17.22 < Industry PE of 35.55
PEG Ratio is 1
Debt to Equity is 0.06 and ICR is 99
ROE is 26%, ROCE is 30% ( 5yr ROCE is 15%)
Sales growth is 42%, 5yr Sales growth is 13%
Profit Growth is 100%, 5yr Profit growth is 17%
Promoter holding is 50%
Latest results - excellent
Technicals
CMP - 1566
Bullish - Above EMA 9, 21,63, 200 on daily charts , RSI(14) is 75
Commentary
Based on the Darvas box method, I expect Natco pharma to continue trading up.
With CMP 1571, it has breached its own all time high with good volumes. As you can see the volumes yesterday was well over the 20 day moving average volume. I expect the trend to continue. The below targets are to ride this wave and catch as much upside as possible with little downside risk.
Target : 1689
Stop Loss : 1420 (If already invested) , more conservative stop loss would be 2-3% below CMP
Disclosure 1 - Invested
Disclosure 2 - Not SEBI Registered
Disclosure 3 - This is Not investment advice. Treat it as educational
Natco Pharma Limited - Breakout Setup, Move is ON...#NATCOPHARM trading above Resistance of 1514
Next Resistance is at 1957
Support is at 1164
Here are previous charts:
Chart is self explanatory. Levels of breakout, possible up-moves (where stock may find resistances) and support (close below which, setup will be invalidated) are clearly defined.
Disclaimer: This is for demonstration and educational purpose only. This is not buying or selling recommendations. I am not SEBI registered. Please consult your financial advisor before taking any trade.
Natco Pharma Limited - Breakout Setup, Move is ON...#NATCOPHARM trading above Resistance of 1090
Next Resistance is at 1514
Support is at 942
Here are previous charts:
Chart is self explanatory. Levels of breakout, possible up-moves (where stock may find resistances) and support (close below which, setup will be invalidated) are clearly defined.
Disclaimer: This is for demonstration and educational purpose only. This is not buying or selling recommendations. I am not SEBI registered. Please consult your financial advisor before taking any trade.
Natco Pharma 2x Possibility in 2 Years based on weekly BreakoutNatco Pharma 2x Possibility in 2 Years based on weekly Breakout.
Weekly Charts shows strong uptrend in Progress with Breakout from previous Highs.
LTP - 1200
SL - 1000
Targets - 2400+
Timeframe - 2-3 Years
Happy Investing.
NATCO PHARMA LTD ANALYSIS 24 MAY 24 LONG NATCO PHARMA LTD ANALYSIS 24 MAY 24 LONG
Investment type : short term (3-12 mnths)
Cmp: 1025
R:R= 1:2
Pattern formed : Inverted head and shoulder
Expected gains : 7% - 16.50%
Bullish levels : -
Level 1 : 1068.20
Level 2 : 111.6.10
Level 3 : 1193.30
SL: 932.20
this technical analysis is purely for education purpose only we did not recommend to invest as per our analysis for investment plz consult financial advisor .
did you see how perfect inverted head and shoulder pattern was formed .
Natco Pharma, the road ahead?Its been a journey of parallel channels for Natco Pharma share price and one believes that it will continue to tread within the broad confines of the longer term monthly channel
Price has now found the resistance area of the channel which started from the lows of the covid (in blue). However, with the earnings on lenalidomide still some 15-18 months away from reaching peak levels, atleast in volume terms, by that time the street should hear expected positive news on some of the points listed below:
- new successful para IV filings and launches from existing tentative or final approved list,
- fixing the usfda cloud over kothur formulations plant,
- traction on the much anticipated brownfield acquisition,
- their CAR T investment growing into something tangible in value terms,
- substantial increase in foreign subsidiary business
- domestic formulation sales getting boost due to possible semalglutide launch
- scaling up of crop health science business
therefore looking at the hanging man on WCB I believe that whether for profit booking or geo political or general broader market sentiment it can correct in the immediate shorter term, however, the bullish thesis remains for the fundamental reasons enumerated above.. The first target from here seems to be around 2500 which can be plotted either by box breakout (from 2017 highs) or a rounding bottom (from 2021 highs) or simply the width of the blue parallel channel if and when it breaks out...
The principle of polarity suggests that price may not close below the line plotted by taking the highs of 2017 and 2021 (the pink dotted line) this area should be our longer term stop loss and a time to revisit the bullish thesis.
NATCO PHARMANSE:NATCOPHARM
Natco Pharma is still looking good in a technical point of view. It formed a cup and holder pattern and it is in a bullish momentum right now. Looks undervalued fundamentally for me.
Did not know that I can publish my ideas with the community on trading view.
Had analysed this stock couple of months ago only.
Will keep giving updates regularly from now on.
Welcome to the month of volatility for the Magic Pill
February 2024 is the month of volatility and true to form even technical resistance lines are hovering above .. the final decision of the usfda over the kothur plant inspection will be out and the q3 expected blip in the results due to the accounting policy of the booking sales and profit share of gRevlimid drug .. Meanwhile the API plant in Manali, Chennai is back running post a brief halt in production due to flooding issues in the vicinity and the US lawsuit against the company has been dropped while the export oriented production units of the company must be busy manufacturing gRevlimid for the new calendar year at higher volumes than the previous year.. bottom line.. hold her steady!
Time has come for Natco to repeat the cycleExplaining the current impasse in fibonacci terms:
> In the previous upmove 0.618 was the resistance from which share price retreated despite blockbuster earnings coinciding with a slew of negative news..
> After finally exploding through 0.618 level, the next logical resistance level of 0.786 is the new barrier.... Once it overcomes this resistance it may travel all the way to the ATH level
>Last May post Q1 results the party had started for Natco Pharma, the cycle may repeat this time around
